Britannia Life Sciences Inc. (CSE:BLAB)

Britannia Life Sciences Statistics

Total Valuation

CSE:BLAB has a market cap or net worth of CAD 15.41 million. The enterprise value is -223,138.

Market Cap	15.41M
Enterprise Value	-223,138

Important Dates

The last earnings date was Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

CSE:BLAB has 162.25 million shares outstanding.

Current Share Class	162.25M
Shares Outstanding	162.25M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	37.22%
Owned by Institutions (%)	n/a
Float	101.86M

Valuation Ratios

The trailing PE ratio is 1.94.

PE Ratio	1.94
Forward PE	n/a
PS Ratio	97.76
PB Ratio	0.89
P/TBV Ratio	0.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.01
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.55, with a Debt / Equity ratio of 0.01.

Current Ratio	3.55
Quick Ratio	3.44
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-542.49

Financial Efficiency

Return on equity (ROE) is 67.82% and return on invested capital (ROIC) is -49.99%.

Return on Equity (ROE)	67.82%
Return on Assets (ROA)	-7.05%
Return on Invested Capital (ROIC)	-49.99%
Return on Capital Employed (ROCE)	-14.44%
Weighted Average Cost of Capital (WACC)	3.35%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, CSE:BLAB has paid 1.67 million in taxes.

Income Tax	1.67M
Effective Tax Rate	17.63%

Stock Price Statistics

The stock price has increased by +35.71% in the last 52 weeks. The beta is -0.16, so CSE:BLAB's price volatility has been lower than the market average.

Beta (5Y)	-0.16
52-Week Price Change	+35.71%
50-Day Moving Average	0.09
200-Day Moving Average	0.08
Relative Strength Index (RSI)	46.41
Average Volume (20 Days)	166,982

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CSE:BLAB had revenue of CAD 157,677 and earned 20.49 million in profits. Earnings per share was 0.13.

Revenue	157,677
Gross Profit	-187,151
Operating Income	-2.50M
Pretax Income	9.50M
Net Income	20.49M
EBITDA	-2.39M
EBIT	-2.50M
Earnings Per Share (EPS)	0.13

Balance Sheet

The company has 15.89 million in cash and 248,559 in debt, with a net cash position of 15.64 million or 0.10 per share.

Cash & Cash Equivalents	15.89M
Total Debt	248,559
Net Cash	15.64M
Net Cash Per Share	0.10
Equity (Book Value)	17.23M
Book Value Per Share	0.11
Working Capital	12.19M

Cash Flow

Operating Cash Flow	-4.15M
Capital Expenditures	n/a
Depreciation & Amortization	103,175
Net Borrowing	-1.12M
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is -118.69%, with operating and profit margins of -1,582.64% and 12,993.71%.

Gross Margin	-118.69%
Operating Margin	-1,582.64%
Pretax Margin	6,022.42%
Profit Margin	12,993.71%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:BLAB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	132.92%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 18, 2021. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 18, 2021
Split Type	Reverse
Split Ratio	0.1

Scores

CSE:BLAB has an Altman Z-Score of 1.74 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.74
Piotroski F-Score	2